Clinical Trial: A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07255404) titled 'A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer' on Nov. 20.

Brief Summary: This study will enroll adults with confirmed metastatic pancreatic ductal adenocarcinoma (PDAC, systemic PDAC treatment naive), Eastern Cooperative Oncology Group performance status (ECOG PS) 0-1, and adequate organ function. Participants will receive pumitamig (BNT327) in combination with chemotherapy.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Pancreatic Ductal Adenocarcinoma (PDAC)

Interve...